期刊文献+

表皮生长因子受体及Ⅲ型突变体在食管癌的表达及意义 被引量:7

Expression and significance of epidermal growth factor receptor and its variant Ⅲ in human esophageal carcinoma
暂未订购
导出
摘要 背景与目的:已有研究显示表皮生长因子受体(epidermal growth factor receptor,EGFR)及Ⅲ型突变体(epidermal growth factor receptor variant Ⅲ,EGFRv Ⅲ)在一系列恶性肿瘤的发生发展中起重要作用,但EGFR、EGFRvⅢ与食管癌的关系目前尚未明确。本研究探讨EGFR及EGFRvⅢ与食管癌组织发生发展的关系。方法:应用免疫组织化学及蛋白印迹实验(Western Blot)检测66例人食管癌组织及癌旁正常组织EGFR及EGFRvⅢ表达,评价EGFR及EGFRvⅢ在食管癌患者的性别、年龄、TNM分期及病理分级等临床参数组的表达分布。Pearson相关性检验分析EGFR及EGFRvⅢ表达相关性。结果:免疫组化显示EGFR、EGFRvⅢ在肿瘤组织表达的平均灰度净值分别为25.4±3.2、22.5±4.2,在癌旁正常食管组织平均灰度净值分别为5.0±3.5、5.5±3.0,肿瘤组织与正常组织相比差异均有显著性(P<0.000)。Western Blot显示EGFR、EGFRvⅢ在肿瘤组织表达的平均灰度净值分别为1.37±0.41、0.83±0.15,在瘤旁正常食管组织平均灰度净值分别为0.21±0.09、0.08±0.05,肿瘤组织与正常组织相比差异均有显著性(P<0.05)。在性别、年龄、肿瘤大小和生长方式方面EGFR、EGFRvⅢ的表达分布差异均无显著性(P>0.05),而在TNM分期、病理分级和淋巴结转移方面两者差异均有显著性(P<0.05)。免疫组化检测两蛋白表达净灰度值相关系数r为0.701(P<0.0001),Western Blot检测两种蛋白表达相关系数r为0.556(P=0.031)。两种研究方法均提示EGFR与EGFRvⅢ在食管癌中的表达成较好线性正相关性。结论:EGFRvⅢ在食管癌特异性表达,EGFR与EGFRvⅢ在食管癌中的表达呈线性正相关,提示EGFR与EGFRvⅢ与食管癌发生、发展密切相关。 Background and purpose:It has been reported that epidermal growth factor receptor(EGFR)and epidermal growth factor receptor variant Ⅲ(EGFRvⅢ)play important roles in the progression of various cancers.This research was to detect the expression and relation of EGFR and epidermal growth factor receptor variant Ⅲ(EGFRvⅢ)to human esophageal carcinoma.Methods:In 66 human esophageal carcinoma tissues,the expression of EGFR and EGFRvⅢ were detected by immunohistochemistry and western-blot.The expression of EGFR and EGFRvⅢ along with the patients' clinicopathologic factors was retrospectively analyzed.Correlation analysis between EGFRvⅢ and EGFR was analyzed by Pearson correlation coefficient.Results:The average gray scale values of EGFR in esophageal carcinoma and normal tissues by immunohistochemistry were 25.4±3.2 and 5.0±3.5,which showed a signifi cant difference(t=5.574,P=0.000).And the average gray scale values of EGFRvⅢ in esophageal carcinoma and normal tissues were 22.5±4.2 and 5.5±3.0,which also showed a signifi cant difference(t=6.701,P=0.000).The average gray scale values of EGFR in esophageal carcinoma and normal tissues respectively by western-blot were 1.37±0.41 and 0.21±0.09,which showed a signifi cant difference(t=10.704,P=0.000)And the average gray scale values of EGFRvⅢ respectively were 0.828±0.15 and 0.083±0.049,which had a significant difference(t=9.362,P=0.000).Significant differences were observed in TNM-stage,lymphatic metastasis and tumor classifi cation in both the expression of EGFR(P0.05)and EGFRvⅢ(P0.05),and but there were no obvious differences in gender,age,tumor size,growth pattern in both the expression of EGFR(P0.05)and EGFRvⅢ(P0.05).Correlation analysis showed that there was strong association of the expression between EGFR and EGFRvⅢ both detected by immunohistochemistry(r=0.701,P0.0001)and western-blot respectively(r=0.556,P=0.031).Conclusion:Our data suggests that EGFRvⅢ is over-expressed in human esophageal carcinoma.Combination of EGFR and EGFRvIII could be useful markers for tumorgenesis and differentiation of human esophageal carcinoma.
出处 《中国癌症杂志》 CAS CSCD 北大核心 2009年第10期729-734,共6页 China Oncology
基金 国家自然科学基金资助项目(No:30600744)
关键词 表皮生长因子受体 表皮生长因子受体Ⅲ型突变体 食管癌 epidermal growth factor receptor epidermal growth factor receptor variant Ⅲ esophageal carcinoma
  • 相关文献

参考文献8

  • 1Arteaga CL. Epidermal growth factor receptor dependence in human tumors: more than just expression [ J ] . Oncologist, 2002, 7 (Suppl 4):31-39.
  • 2Itakura Y, Sasano H, Shiga C, et al. Epidermal growth factor receptor overexpression in esophageal carcinoma. An immunohistochemical study correlated with clinicopathologic findings and DNA amplification [ J ] . Cancer, 1994, 74(3):795-804.
  • 3Yaden Y, Sliwkowski MX. Untangling the ErbB signaling network [ J ] , Nat Rev Mol Biol, 2001, 2 (2) :127-137.
  • 4宋国红,任军,张力健,方健,邸立军.非小细胞肺癌表皮生长因子受体基因主要突变类型快速简便的检测方法[J].中国癌症杂志,2009,19(5):347-352. 被引量:1
  • 5Moscatello DK, Montgomery RB, Sundareshan P, et al. Transformational and altered signal transduction by a naturally occurring mutant EGF receptor [ J ] . Oncogene, 1996, 13(1): 85 -96.
  • 6Pawlowski V, Revillion F, Hebbar M, et al. Prognostic value of the type Ⅰ growth factor receptors in a large series of human primary breast cancers quantified with a real-time reverse transcription-polymerase chain reaction assay [ J ] . Clin Cancer Res, 2000, 6(11):4217-4225.
  • 7赵荫农,何妮,欧超,曹骥,陈军,刘剑勇,袁卫平.乳腺肿瘤组织中EGFR与EGFRv Ⅲ的表达及临床意义[J].中华肿瘤防治杂志,2007,14(3):185-188. 被引量:5
  • 8Ohtsuka K, Ohnishi H, Furuyashiki G, et al. Clinicopathological and biological significance of tyrosine kinase domain gene mutations and overexpression of epidermal growth factor receptor for lung adenocarcinoma [ J ] . J Thorac Oncol, 2006, 1(8):787-795.

二级参考文献12

  • 1欧超,吴飞翔,罗元,曹骥,赵荫农,袁卫平,李瑗,苏建家.表皮生长因子受体Ⅲ型突变体在肝细胞癌中的表达及意义[J].癌症,2005,24(2):166-169. 被引量:19
  • 2BaoMingQIN,XiaoCHEN,JingDeZHU,DuanQingPEI.Identification of EGFR kinase domain mutations among lung cancer patients in China:implication for targeted cancer therapy[J].Cell Research,2005,15(3):212-217. 被引量:69
  • 3董强刚,黄进肃,黄建,卢丽琴,杨立民.肺癌靶向治疗研究进展与我国肺癌的EGFR基因突变概况[J].肿瘤,2005,25(6):625-628. 被引量:35
  • 4Yaden Y,Sliwkowski M X.Untangling the ErbB signaling network[J],Nat Rev Mol Biol,2001,2(2):127-137.
  • 5Brideges A J.The rationale and strategy used to develop a series of highly potent,irreversible,inhibitors of The epidermal growth factor receptor family of tyrosine kinases[J].Curr Med Chem,1999,6(9):825-843.
  • 6Wikstrand C J,Reist C J,Archer G E,et al,The Class Ⅲ variant of epidermal growth factor receptor(EGFRv Ⅲ):Charaterization and utilization as immunotherapeutie target[J].J Neuroviro,1998,4(2):148-158.
  • 7Klapper L N,kirschbaum M A,Sela M,et al.Biochemical and clinical implications of the ErbB/HER signaling network of growth facter receptors[J].Adv Cancer Res,2000,77(10):25-79.
  • 8Moscatello D K,Holado-Madruga M,Godwin A K,et al.Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors[J].Cancer Res,1995,55(23):5536-5539.
  • 9Wikstrand C J,Reist C J,Archer G E,et al.The Class Ⅲ variant of epidermal growth factor receptor(EGFRv Ⅲ):Charaterization and utilization as immunotherapeutie target[J].J Neuroviro,1998,4(2):148-158.
  • 10Pedersen M W,Meltorn M,Damstrll P L,et al.The type Ⅲ epidermal growth factor receptor mutation,biological,Significant and potential target for anti-cancer therapy[J].Ann Oncol,2001,12(6):745-10.

共引文献4

同被引文献125

引证文献7

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部